Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Eurofins Scientific has signed an agreement to acquire Exova’s food, water and pharmaceutical testing business in the UK & Ireland, comprising 10 laboratories, for approximately GBP 18m, subject to closing adjustments. The transaction is expected to ...
read more
Crown Bioscience, a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the launch of HuScreenTM, a new Translational Oncology service platform ...
read more
Aesica Pharmaceuticals, a global pharmaceutical contract development and manufacturing organization (CDMO), provides a novel, modular based solution that provides pharmaceutical customers with a highly flexible, efficient and reliable technological ...
read more
BioPharma Services USA, has been awarded a 5-year, $20 million contract with the Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA). The contract is to conduct in vivo studies of generic drug ...
read more
ClinTec International continues to deliver strong growth and further international expansion with the opening of two new offices in Spain, alongside the appointment of Carlos Palacios as the company’s new Regional Manager for Spain and Portugal.
read more
ProBioGen, a CDMO of complex glycoproteins and corresponding technologies, has announced that Thermo Fisher Scientific has licensed its GlymaxX® technology for use in development of allergy diagnostics.
read more
Catalent Pharma Solutions, a provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services, has announced the introduction of its Peel-ID™ label, a new standard...
read more
Avista Pharma Solutions, Inc. has initiated a significant expansion and enhancement of its contract testing facility in Agawam, Mass.
read more
Envigo has announced the appointment of Scott Schulz, MBA, to the post of Director, North American (NA) Operations. In this role, Scott will optimize operational performance and service delivery across the company’s North American based production ...
read more
Gilead Sciences has announced two appointments to the company’s senior leadership team. Kevin Young CBE has been appointed Chief Operating Officer, and Martin Silverstein, MD has been appointed Executive Vice President, Strategy.
read more
Despite R&D-focused pharmaceutical executives recognizing digital as the primary driver to be more patient-outcome focused, only half of them are currently adopting digital, according to a new report from Accenture.
read more
Dr. Reddy’s Laboratories has announced the acquisition of a portfolio of over-the-counter (OTC) brands in the cough-and-cold, pain, and dermatology categories. The company acquired six OTC brands from Ducere Pharma, including DOAN’S®, BUFFERIN®, ...
read more
Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization (CRO) to the biopharmaceutical and medical device industries, is pleased to welcome Miguel Salcedo to its management team as Regional Director, ...
read more
SOLA Biosciences has announced a CARMA (Cooperative Research and Manufacturing Agreement) with SBH Sciences (SBH), a bio-incubator and innovative preclinical contract research organization.
read more
Boehringer Ingelheim and Inventiva, a French biopharmaceutical company specializing in the development of innovative therapies for fibrosis, oncology and orphan diseases, have announced a new multi-year research and drug discovery collaboration and ...
read more